Gujarat Terce Laboratories Share Price

Gujarat Terce Laboratories Share Price

  • 34.50-0.49 (-1.40%)
BSE
  • Closed
  • As On: 16 Jun, 2026, 03:50 PM IST
Loading...
Open-
High-
Low-
Prev Close-
Volume-
VWAP(₹)-

Key Metrics

PE Ratio(x)12.10
EPS - TTM(₹)2.85
MCap(₹ Cr.)26.88
MCap Rank161
PB Ratio(x)2.80
Div Yield(%)-
Face Value(₹)10.00
52W High(₹)59.78
52W Low(₹)29.00
MCap/Sales0.51
Beta(1 Month)0.42
BV/Share(₹)12.49

Gujarat Terce share price insights

  • ROE Outperforming 5 Year Average

    Company delivered ROE of 22.63% in year ending Mar 31, 2026 outperforming its 5 year avg. of 1.72%. (Source: Standalone Financials)
  • Topline Contraction

    Sales de-grew by 5.33%. Company witnessed revenue contraction for the first time in last 3 years. (Source: Standalone Financials)
  • Employee & Interest Expense

    Company has spent less than 1% of its operating revenues towards interest expenses and 33.84% towards employee cost in the year ending Mar 31, 2026. (Source: Standalone Financials)
  • Gujarat Terce Share Price Update

    Gujarat Terce Laboratories Ltd. share price moved down by -1.40% from its previous close of Rs 34.99. Gujarat Terce Laboratories Ltd. stock last traded price is 34.50

    Share PriceValue
    Today/Current/Last34.50
    Previous Day34.99

Found Insights useful?

Gujarat Terce Share Price Returns

1 Day-1.4%
1 Month-5.43%
3 Months-8.1%
1 Year-39.31%
3 YearsN.A.
5 Years255.67%

Gujarat Terce Share Recommendations

No Recommendations details available for this stock.
Check out other stock recos.

Share Analysis

EARNINGS
FUNDAMENTAL
RELATIVE VALUATION
RISK
PRICE MOMENTUM

Unlock Stock Score, Analyst' Ratings & Recommendations

  • Score on 10-point scale
  • Ratings by analysts
  • Stock performance
JOIN ET PRIME

Financials

  • QuarterlyDec 2019Sep 2019Jun 2019Sep 2018
    Total Income10.1211.166.947.98
    Total Income Growth (%)-9.3160.92-13.0118.23
    Total Expenses9.729.378.117.78
    Total Expenses Growth (%)3.7615.534.226.08
    EBIT0.411.80-1.170.20
    EBIT Growth (%)-77.42--695.22-
    Profit after Tax (PAT)0.371.69-1.220.10
    PAT Growth (%)-78.25--1,298.23-
    EBIT Margin (%)4.0116.10-16.862.46
    Net Profit Margin (%)3.6415.18-17.551.27
    Basic EPS (₹)0.500.230.000.01
    Mar 2026Dec 2025Sep 2025Jun 2025Mar 2025
    Total Income11.4812.4212.9810.9512.41
    Total Income Growth (%)-7.60-4.3218.57-11.79-2.64
    Total Expenses11.2511.2511.1310.9711.37
    Total Expenses Growth (%)-0.061.071.49-3.55-2.67
    EBIT0.231.171.85-0.021.04
    EBIT Growth (%)-80.31-36.81--102.09-2.39
    Profit after Tax (PAT)0.100.761.40-0.04-3.39
    PAT Growth (%)-86.73-45.78---436.42
    EBIT Margin (%)2.009.4014.24-0.208.35
    Net Profit Margin (%)0.886.1310.81-0.40-27.33
    Basic EPS (₹)0.130.951.89-0.06-4.57
    FY 2026FY 2025FY 2024FY 2023FY 2022
    Total Revenue47.8150.5048.3047.1440.44
    Total Revenue Growth (%)-5.334.572.4616.5655.66
    Total Expenses44.3347.1147.7550.0339.69
    Total Expenses Growth (%)-5.91-1.34-4.5626.0439.22
    Profit after Tax (PAT)2.20-0.980.24-1.670.87
    PAT Growth (%)--502.10--291.63-
    Operating Profit Margin (%)7.727.582.54-4.642.85
    Net Profit Margin (%)4.63-1.940.50-3.572.17
    Basic EPS (₹)2.92-1.320.33-2.251.18

    No Data Available

    All figures in Rs Cr, unless mentioned otherwise

    Insights
    • Topline Contraction

      Sales de-grew by 5.33%. Company witnessed revenue contraction for the first time in last 3 years. (Source: Standalone Financials)
    • Employee & Interest Expense

      Company has spent less than 1% of its operating revenues towards interest expenses and 33.84% towards employee cost in the year ending Mar 31, 2026. (Source: Standalone Financials)
  • AnnualFY 2026FY 2025FY 2024FY 2023FY 2022
    Total Assets24.5522.8323.2728.5327.39
    Total Assets Growth (%)7.53-1.89-18.444.1625.64
    Total Liabilities14.8216.3516.1721.6618.86
    Total Liabilities Growth (%)-9.361.11-25.3514.8533.38
    Total Equity9.736.487.116.868.53
    Total Equity Growth (%)50.15-8.863.64-19.5811.36
    Current Ratio (x)1.320.950.920.971.17
    Total Debt to Equity (x)0.130.150.541.060.78
    Contingent Liabilities0.00----

    No Data Available

    All figures in Rs Cr, unless mentioned otherwise

  • AnnualFY 2026FY 2025FY 2024FY 2023FY 2022
    Net Cash flow from Operating Activities1.713.062.600.03-0.44
    Net Cash used in Investing Activities-0.110.46-0.460.62-2.37
    Net Cash flow from Financing Activities0.47-2.83-4.08-0.121.53
    Net Cash Flow2.080.69-1.940.52-1.28
    Closing Cash & Cash Equivalent2.860.780.092.030.01
    Closing Cash & Cash Equivalent Growth (%)266.92765.04-95.560.00-99.29
    Total Debt/ CFO (x)0.760.311.49272.37-15.05

    No Data Available

    All figures in Rs Cr, unless mentioned otherwise

    Insights
    • Cash from Operations vs PAT

      Operating cash flow of Rs 1.71 cr is 0.78 times compared to the reported net profit of Rs 2.2 cr. (Source: Standalone Financials)
  • AnnualFY 2026FY 2025FY 2024FY 2023FY 2022
    Return on Equity (%)22.63-15.103.42-24.3510.22
    Return on Capital Employed (%)26.9437.3610.95-18.228.09
    Return on Assets (%)8.96-4.281.04-5.853.18
    Interest Coverage Ratio (x)22.7810.092.35-2.513.55
    Asset Turnover Ratio (x)2.002.181.851.671.63
    Price to Earnings (x)10.94-46.51163.93-7.4022.27
    Price to Book (x)2.477.005.531.802.27
    EV/EBITDA (x)5.5110.8727.12-9.7418.31
    EBITDA Margin (%)8.618.343.30-3.863.54

    No Data Available

    Insights
    • ROE Outperforming 5 Year Average

      Company delivered ROE of 22.63% in year ending Mar 31, 2026 outperforming its 5 year avg. of 1.72%. (Source: Standalone Financials)

Found Financials useful?

Technicals

Peer Comparison

Shareholding Pattern

  • CategoryNo. of SharesPercentage% Change QoQ
    Promoters31,18,72740.03 %0.00
    Pledge00.00 %0.00
    Others46,72,57359.97 %0.00
  • CategoryMar 2026Dec 2025Sep 2025Jun 2025
    Promoters40.0340.0337.0337.03
    Pledge0.000.000.000.00
    FII0.000.000.000.00
    DII0.000.000.000.00
    Mutual Funds0.000.000.000.00
    Others59.9759.9762.9762.97

Mutual Funds Ownership

No Data Available

Corporate Actions

  • General Meeting

    -

    Jun 01, 2026

    Board Meeting

    Audited Results & A.G.M.

    May 26, 2026

    Board Meeting

    Audited Results & A.G.M.

    May 26, 2026

  • Announced onMeeting on
    May 26, 2026May 29, 2026
    Audited Results & A.G.M.
    May 26, 2026May 27, 2026
    Audited Results & A.G.M.
    Dec 29, 2025Feb 04, 2026
    Quarterly Results
    Nov 03, 2025Nov 08, 2025
    Quarterly Results
    Aug 04, 2025Aug 11, 2025
    Quarterly Results
  • No Data Available

  • No Data Available

  • Announced onEx-Date
    Jul 28, 2011-
    Split: Old FV10.0| New FV:5.0
  • Announced onEx-Date
    Jun 29, 2010-
    Rights ratio: 2 share for every 3 held at a price of Rs 15.0
  • Announced onMeeting on
    Jun 01, 2026Aug 21, 2026
    -
    Jul 28, 2025Aug 21, 2025
    -
    Aug 09, 2024Sep 17, 2024
    -
    Jun 08, 2023Aug 25, 2023
    A.G.M.
    Jun 24, 2021Sep 07, 2021
    Book closure from Sep 1, 2021 to Sep 7, 2021

About Gujarat Terce

Gujarat Terce Laboratories Ltd., incorporated in the year 1985, is a Small Cap company (having a market cap of Rs 26.88 Crore) operating in Pharmaceuticals sector.

Show More

Key Indices Listed On

-

Address

122/2, Ravi Estate,Bileshwarpura,Gandhinagar District, Gujarat - 382729

Executive Leadership

NP

Natwarbhai P Prajapati

Chairman
AP

Aalap Prajapat

Managing Director & CEO
AP

Amrutbhai P Prajapati

Whole Time Director
CA

Chhayaben A Shah

Independent Director
Show More

Auditors

M A Shah & Co.
USS & Associates

FAQs about Gujarat Terce share

  • 1. What's the Gujarat Terce share price today?
    As on 16 Jun, 2026, 03:50 PM IST Gujarat Terce share price is down by 1.40% basis the previous closing price of Rs 34.99. Gujarat Terce share price is Rs 34.50. Return Performance of Gujarat Terce Shares:
    • 1 Week: Gujarat Terce share price moved down by 0.14%
  • 2. What are the returns for Gujarat Terce share?
    Return Performance of Gujarat Terce Shares:
    • 1 Week: Gujarat Terce share price moved down by 0.14%
  • 3. What's the market capitalization of Gujarat Terce?
    Gujarat Terce share has a market capitalization of Rs 26.88 Cr. Within Pharmaceuticals sector, it's market cap rank is 161.
  • 4. What is the PE & PB ratio of Gujarat Terce?
    The PE ratio of Gujarat Terce stands at 12.1, while the PB ratio is 2.76.
  • 5. What is 52 week high/low of Gujarat Terce share price?
    52 Week high of Gujarat Terce share is Rs 59.78 while 52 week low is Rs 29.00

Top Gainers

As on 03:59 PM | 16 Jun 2026
Sonata Software
311.25
50.90 (19.56%)
FACT
997.80
91.75 (10.13%)
MMTC
75.74
5.55 (7.91%)
PG Electroplast
527.45
34.66 (7.04%)
Century Texttiles
1,315.70
75.71 (6.11%)

Top Losers

As on 04:01 PM | 16 Jun 2026
GIC
358.40
-28.86 (-7.45%)
PTC Industries
17,809.00
-847.00 (-4.55%)
NALCO
366.65
-15.71 (-4.11%)
Akums Drugs & Pharma
596.85
-23.11 (-3.73%)
Minda Ind.
1,089.50
-36.21 (-3.22%)

DATA SOURCES: TickerPlant (for live BSE/NSE quotes service) and Dion Global Solutions Ltd. (for corporate data, historical price & volume, F&O data). Sensex & BSE Quotes and Nifty & NSE Quotes are real-time and licensed from BSE and NSE respectively. All timestamps are reflected in IST (Indian Standard Time).

DISCLAIMER: Any and all content on this website including tools/analysis is provided to you only for convenience and on an “as-is, as- available” basis without representation and warranties of any kind. The content and any output of such tools/analysis is for informational purposes only and should not be relied upon or construed as an investment advice or guarantee for any specific performance/returns advice or considered as recommendation for the purchase or sale of any security or investment. You are advised to exercise caution, discretion and independent judgment with regards to the same and seek advice from professionals and certified experts before taking any decisions.

By using this site, you agree to the Terms of Service and Privacy Policy.